Cortechs.ai | Cortechs.ai Red Herring Top 100 North America winner

Cortechs.ai Red Herring Top 100 North America winner

Cortechs.ai recognized as a leading and promising North American startup for innovation and technology.

(San Diego, CA) June 13, 2016 – Cortechs.ai, the leading medical software innovator providing solutions for quantitative brain image analysis, is pleased to announce that it has been selected as a winner for Red Herring’s Top 100 North America award.

Since 1996, Red Herring has been selecting outstanding entrepreneurs and promising startup companies for their innovations and disruptive technologies across a variety of industries. Cortechs.ai joins a distinguished list of companies to be recognized by Red Herring that have gone on to change the way we live and work including Facebook, Twitter, Yahoo, Skype, Salesforce.com, YouTube and eBay.

“The entire team at Cortechs.ai is passionate about developing software solutions that dramatically improve the assessment of the human brain,” said Guri Stark, Cortechs.ai’ CEO.  “We are very excited to be recognized for our proven technological contributions, which provide physicians with innovative tools used in the evaluation of neurological conditions, such as Alzheimer’s disease, brain trauma, multiple sclerosis, epilepsy and brain development.”

Companies were evaluated by Red Herring editorial staff on both quantitative and qualitative criteria for financial performance, technological innovation and intellectual property, management quality, business model, customer footprint and market penetration. This assessment of potential is complemented by a review of the track record and standing of startups relative to their sector peers, allowing Red Herring to see past the “buzz” and make the list a valuable instrument of discovery and advocacy for the most promising new business models in North America.

“In 2016, selecting the top achievers was extremely difficult,” said Alex Vieux, publisher and CEO of Red Herring. “The variety, depth, disruption and traction we saw from the early stage companies to those with significant scale made it one of the toughest vintages to judge. The North America winners are representative of the amazing ecosystem that never ceases to astound, with new and experienced entrepreneurs continuing to push the barriers of innovation. As one of the winners, Cortechs.ai should be proud of its accomplishment under such strong competition.”

For more information about the Red Herring Top 100 North America award, please visit www.redherring.com/events/top-100/.

About Cortechs.ai
Cortechs.ai develops and markets breakthrough medical device software solutions capable of automatically segmenting and quantifying brain structures, making quantitative analysis of the human brain a routine part of clinical practice. Cortechs.ai’ cutting-edge brain imaging analysis provides neurologists, radiologists, and clinical researchers worldwide with a convenient and cost-effective means to quantify subcortical structures to help assess a variety of neurological conditions, such as Alzheimer’s disease, epilepsy, multiple sclerosis, brain trauma and brain development. Please visit cortechs.ai for further information.

More Resources

03/20/2026

Quantitative MRI, the McDonald Criteria, and the Future of Multiple Sclerosis Care

MRI is the foundation for diagnosing and monitoring multiple sclerosis (MS)

03/13/2026

Cortechs Cares: Community Impact and Volunteer Efforts in 2025

Cortechs Cares highlights how our team gave back in 2025 through community volunteer efforts, including an Alzheimer’s Walk and holiday toy drive.

03/11/2026

OnQ™ Prostate: Bringing Quantitative MRI to Prostate Imaging

Advancing prostate MRI with quantitative diffusion biomarkers. OnQ™ Prostate brings objective RSI-based insights to support data-driven cancer evaluation.

03/04/2026

Cortechs.ai and Siemens Healthineers Partner to Expand Global Access to NeuroQuant® Technologies

NeuroQuant® Lesion Surveillance will be integrated into the Siemens Healthineers Digital Marketplace to advance quantitative brain imaging worldwide.

02/25/2026

Cortechs.ai Announces MFDS (KFDA) Approval of Global-Leading NeuroQuant® V5 Platform in South Korea

MFDS approves NeuroQuant® V5 in South Korea, expanding AI-driven volumetric neuroimaging and clinical decision support.

02/24/2026

Financial Conflict Of Interest Policy Applicable To NIH Awards

Scroll to Top